| First Author | Borys SM | Year | 2024 |
| Journal | Sci Immunol | Volume | 9 |
| Issue | 102 | Pages | eadl2967 |
| PubMed ID | 39705335 | Mgi Jnum | J:362055 |
| Mgi Id | MGI:7868548 | Doi | 10.1126/sciimmunol.adl2967 |
| Citation | Borys SM, et al. (2024) NK cells restrain cytotoxic CD8(+) T cells in the submandibular gland via PD-1-PD-L1. Sci Immunol 9(102):eadl2967 |
| abstractText | The increasing use of anti-programmed cell death 1 (PD-1) immune checkpoint blockade has led to the emergence of immune-related adverse events (irAEs), including dysfunction of the submandibular gland (SMG). In this study, we investigated the immunoregulatory mechanism contributing to the susceptibility of the SMG to irAEs. We found that the SMGs of PD-1-deficient mice and anti-programmed cell death ligand 1 (PD-L1)-treated mice harbor an expanded population of CD8(+) T cells. We demonstrate that natural killer (NK) cells expressing PD-L1 tightly regulate CD8(+) T cells in the SMG. When this immunoregulation is disrupted, CD8(+) T cells clonally expand and acquire a unique transcriptional profile consistent with T cell receptor (TCR) activation. These clonally expanded cells phenotypically overlapped with cytotoxic GzmK(+) CD8(+) T autoimmune cells identified in patients with primary Sjogren's syndrome. Understanding how NK cells modulate CD8(+) T cell activity in the SMG opens new avenues for preventing irAEs in patients undergoing checkpoint blockade therapies. |
